Abstract
This review provides the complex interaction between human immunodeficiency virus (HIV) infection and gut microbiota. HIV infection exerts chronic effects by impairing the immune system, closely linked with alterations in gut microbiota. While advances in highly active antiretroviral therapy have achieved HIV undetectable in the bloodstream, persistent microbial translocation in the gut microbiota despite antiviral treatment leads to systemic immune activation and chronic inflammation in people living with HIV (PLHIV). There is the need for elucidating which specific microbes and their byproducts that contribute to immune activation and chronic inflammation in PLHIV. Furthermore, gaining a deeper understanding of the connection between HIV infection and metabolic disorders holds significant potential for addressing and managing conditions like premature aging and metabolic diseases. Monitoring alterations in gut microbiota composition shows promise in developing diagnostic markers and therapeutic potential for metabolic disorders in PLHIV.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
